TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/27/22 16:29 | 5/25/22 | RAPT | Rapt Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Column Group Ii, LP | CA | T | P | 24 | 12.45 | 0 | 2 | 0 | 3,189 | I | |||||||||||||||
5/27/22 16:24 | 5/25/22 | RAPT | Rapt Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Column Group Ii, LP | CA | T | P | 24 | 12.45 | 0 | 2 | 0 | 3,189 | I | |||||||||||||||
5/25/22 16:20 | 5/23/22 | RAPT | Rapt Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Column Group Ii, LP | CA | T | P.m | 324 | 12.19 | 0 | 27 | 1 | 3,189 | I | |||||||||||||||
5/25/22 16:19 | 5/23/22 | RAPT | Rapt Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Column Group Ii, LP | CA | T | P.m | 324 | 12.19 | 0 | 27 | 1 | 3,189 | I | |||||||||||||||
5/12/22 17:29 | 5/10/22 | RAPT | Rapt Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Column Group Ii, LP | CA | T | P | 13,339 | 10.67 | 0 | 1,250 | 64 | 3,188 | I | |||||||||||||||
5/12/22 17:28 | 5/10/22 | RAPT | Rapt Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Column Group Ii, LP | CA | T | P | 13,339 | 10.67 | 0 | 1,250 | 64 | 3,188 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |